Institutional Research Cancer Epidemiology Fellowship

此申请是T32 CA 09314-癌症培训计划的5年续期（34-38年级） 约翰霍普金斯布隆伯格公共卫生学院流行病学、预防和控制。我们的使命是 培养博士前学生和博士后研究员，使他们成为推动知识发展的前沿领导者a） 癌症的原因，包括当地、国家和地区人群中固有的和可改变的因素， B）如何预防和减少当地、国家和全球癌症负担， 交流更好地理解影响癌症发展和促进健康的行为 存活率，ii）鉴定用于癌症早期检测的新标志物，和iii）鉴定和解决癌症 差异，包括弱势群体和护理障碍;以及c）如何转化、实施和 评估癌症流行病学，预防和控制发现到人群中。我们的目标是创造一个丰富的 和互动的环境，为学员增强了高度创新，生产力和协作的癌症 由公共卫生学院的观察，基础和临床科学家进行的研究， 医学和癌症中心。该计划有3个轨道：1）癌症病因学和预防，包括 转化研究; 2）癌症遗传流行病学，包括基因组学和表观遗传学; 3）癌症 控制，包括差距，通信和烟草。6名博士前和3名博士后学员专注于 跨轨道共享要素方案：关于实质性和方法学主题的教学课程， 研究伦理;交互式信息交换;教学、交流、撰写资助;博士前或博士后 研究;以及针对具体项目的教育、研究和职业指导。我们强调必须 开发和测试新的假设和跨学科合作。通过共享元素，学员 接触当前的主题，如转化研究，分子流行病学，新兴的风险因素， 研究和筛查中的方法学问题，差异，沟通，以及流行病学在风险中的应用 评估和公共政策。16个指导者，部分是根据咨询和研究的记录而选择的，是主要的 导师28个附属机构提供特定癌症、生物统计学和实验室暴露方面的尖端专业知识 考核指导委员会与主任一起负责受训人员的甄选/监测， 随着癌症研究的发展，培训时间为4-5年的前和2年的博士后 实习生我们有一个很好的记录：在过去10年中，33名博士前和15名博士后学员患有癌症 研究培训和职业成功。从大量的申请人中，最好的候选人被招募。学员 代表不同的背景;我们收到了4个治愈补充。总而言之，该计划旨在a） 为学员提供进行最高水平、最先进、 合作，转化癌症研究，B）培养他们成为创新思想家，c）发展教学和 沟通技巧，d）准备他们在学术界或其他地方领导国家的癌症研究议程。

This application is for a 5-year renewal (Years 34-38) of T32 CA09314 - Training Program in Cancer Epidemiology, Prevention, and Control at Johns Hopkins Bloomberg School of Public Health. Our mission is to train pre-doctoral students and post-doctoral fellows to be leaders at the forefront of advancing knowledge of a) causes of cancer, including inherent and modifiable factors in human populations locally, nationally, and globally; b) how to prevent and reduce burden of cancer locally, nationally, and globally by i) providing and communicating a better understanding of behaviors that influence cancer development and promote healthy survivorship, ii) identifying new markers for early detection of cancer, and iii) identifying and addressing cancer disparities including in vulnerable populations and barriers to care; and c) how to translate, implement, and evaluate cancer epidemiology, prevention, and control discoveries into populations. Our goal is to create a rich and interactive environment for trainees augmented by highly innovative, productive, and collaborative cancer research conducted by observational, basic, and clinical scientists at the Schools of Public Health and Medicine and Cancer Center. The Program has 3 tracks: 1) Cancer Etiology and Prevention, including translational research; 2) Genetic Epidemiology of Cancer, including genomics and epigenetics; and 3) Cancer Control, including disparities, communication, and tobacco. 6 pre- and 3 post-doctoral trainees pursue focused programs of shared elements across tracks: didactic courses on substantive and methodologic topics and research ethics; interactive information exchange; teaching, communication, grant writing; pre- or post-doctoral research; and program-specific education, research, and career mentoring. We stress the importance of developing and testing novel hypotheses and collaborating across disciplines. Via shared elements, trainees are exposed to current topics such as translational research, molecular epidemiology, emerging risk factors, methodologic issues in research and screening, disparities, communication, and use of epidemiology in risk assessment and public policy. 16 Preceptors, selected in part for records of advising and research, are primary mentors. 28 Affiliates provide cutting-edge expertise in specific cancers, biostatistics, and laboratory exposure assessment. With the Director, the Steering Committee is responsible for trainee selection/monitoring, and program refinement as cancer research evolves. Training duration is 4-5 yrs for pre- and 2 yrs for post-doctoral trainees. We have a strong record: the 33 pre- and 15 post-doctoral trainees in the past 10 years had cancer research training and career success. From a large pool of applicants, best candidates are recruited. Trainees represent diverse backgrounds; we received 4 CURE supplements. In summary, the Program is designed to a) provide trainees with a multidisciplinary background essential to conduct highest caliber, state-of-the-art, collaborative, translational cancer research, b) nurture them to be innovative thinkers, c) develop teaching and communication skills, d) prepare them to lead the nation's cancer research agenda in academia or elsewhere.